During both study years, only arm soreness (for 1997-1998, 315 [53%] of 594 vs 106 [18%] of 586 [P<.001]; for 1998-1999, 309 [53%] of 582 vs 130 [22%] of 595 [P<.001]) and redness at the injection site (for 1997-1998, 86 [14%] of 594 vs 34 [6%] of 586 [P<.001]; for 1998-1999, 92 [16%] of 582 vs 45 [8%] of 595 [P<.001]) were reported more often by vaccine recipients than by placebo recipients. No other adverse effects, including fever, myalgia, headache, fatigue, rhinitis, or sore throat, were reported significantly more often by vaccine recipients, nor did they report significantly more lost workdays or physician visits." 

http://jama.jamanetwork.com/article.aspx?articleid=193139